The markets opened lower with the Dow falling 45 points to 17,537 as crude oil prices slipped. Nasdaq dropped 22 points to 4,799.
On the upside
Celator Pharmaceuticals (Nasdaq: CPXX) priced its public offering of 4 million common stock at the price of $9.50 per share.
The journal Proceedings of the National Academy of Sciences published upbeat clinical data about Cerulean Pharma’s (Nasdaq: CERU) CRLX101.
TheStreet identified Pernix Therapeutics (Nasdaq: PTX) as one of six biotech stocks under $10 that is poised to breakout.
On the downside
Pinnacle Foods (NYSE: PF) chief executive Robert J. Gamgort will leave the company to assume the chief executive position at Keurig Green Mountain (Nasdaq: GMCR).
SunEdison (NYSE: SUNE) stock extended its losses.
Retreating gold prices weigh down shares of Yamana Gold (NYSE: AUY).
In the broad market, declining issues outpaced advancers by a margin of 5 to 2 on the NYSE by more than 2 to 1 on Nasdaq. The broader S&P 500 fell 6 points to 2,043. Bitcoin held steady at $415.